Ambulatory Blood Pressure Monitoring Devices Market (2024 - 2030) Size, Share & Trends Analysis Report By Product (Ambulatory Blood Pressure Monitors, Instrument & Accessories), By Type (Blood Pressure Cuffs, Others), By End-use, By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product
                        1.2.2. End-use
                        1.2.3. Regional scope
                        1.2.4. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in Asia Pacific
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Product outlook
                        2.2.2. End-use outlook
                        2.2.3. Regional outlook
                    2.3. Competitive Insights
Chapter 3. Ambulatory Blood Pressure Monitoring Devices Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                        3.2.2. Market restraint analysis
                        3.2.3. Market opportunity analysis
                            3.2.3.1. Increasing prevalence of chronic diseases
                    3.3. Ambulatory Blood Pressure Monitoring Devices Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
                    3.4. Ambulatory Blood Pressure Monitoring Devices Market: Prevalence Data, By Region
                        3.4.1. North America
                            3.4.1.1. U.S.
                            3.4.1.2. Canada
                            3.4.1.3. Mexico
                        3.4.2. Europe
                            3.4.2.1. UK
                            3.4.2.2. Germany
                            3.4.2.3. France
                            3.4.2.4. Italy
                            3.4.2.5. Spain
                            3.4.2.6. Denmark
                            3.4.2.7. Sweden
                            3.4.2.8. Norway
                        3.4.3. Asia Pacific
                            3.4.3.1. Japan
                            3.4.3.2. China
                            3.4.3.3. India
                            3.4.3.4. South Korea
                            3.4.3.5. Australia
                            3.4.3.6. Thailand
                        3.4.4. Latin America
                            3.4.4.1. Brazil
                            3.4.4.2. Argentina
                        3.4.5. Middle East and Africa (MEA)
                            3.4.5.1. South Africa
                            3.4.5.2. Saudi Arabia
                            3.4.5.3. UAE
                            3.4.5.4. Kuwait
Chapter 4. Ambulatory Blood Pressure Monitoring Devices Market: Product Estimates & Trend Analysis
                    4.1. Product Market Share, 2023 & 2030
                    4.2. Segment Dashboard
                    4.3. Global ambulatory blood pressure monitoring devices Market by Product Outlook
                    4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                    4.5. Ambulatory blood pressure monitors
                        4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.6. Instrument & accessories
                        4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.6.2. Blood Pressure Cuffs
                            4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.6.3. Others
                            4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Ambulatory Blood Pressure Monitoring Devices Market: End-use Estimates & Trend Analysis
                    5.1. End-use Market Share, 2023 & 2030
                    5.2. Segment Dashboard
                    5.3. Global ambulatory blood pressure monitoring devices Market by End-use Outlook
                    5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        5.4.1. Hospitals
                            5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
                        5.4.2. Ambulatory Surgical Centers & Clinics
                            5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.3. Homecare
                            5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Ambulatory Blood Pressure Monitoring Devices Market: Regional Estimates & Trend Analysis by Product & End-use
                    6.1. Regional Market Share Analysis, 2023 & 2030
                    6.2. Regional Market Dashboard
                    6.3. Global Regional Market Snapshot
                    6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
                    6.5. North America
                        6.5.1. U.S.
                            6.5.1.1. Key country dynamics
                            6.5.1.2. Regulatory framework/ reimbursement structure
                            6.5.1.3. Competitive scenario
                            6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
                        6.5.2. Canada
                            6.5.2.1. Key country dynamics
                            6.5.2.2. Regulatory framework/ reimbursement structure
                            6.5.2.3. Competitive scenario
                            6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
                        6.5.3. Mexico
                            6.5.3.1. Key country dynamics
                            6.5.3.2. Regulatory framework/ reimbursement structure
                            6.5.3.3. Competitive scenario
                            6.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
                    6.6. Europe
                        6.6.1. UK
                            6.6.1.1. Key country dynamics
                            6.6.1.2. Regulatory framework/ reimbursement structure
                            6.6.1.3. Competitive scenario
                            6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
                        6.6.2. Germany
                            6.6.2.1. Key country dynamics
                            6.6.2.2. Regulatory framework/ reimbursement structure
                            6.6.2.3. Competitive scenario
                            6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
                        6.6.3. France
                            6.6.3.1. Key country dynamics
                            6.6.3.2. Regulatory framework/ reimbursement structure
                            6.6.3.3. Competitive scenario
                            6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
                        6.6.4. Italy
                            6.6.4.1. Key country dynamics
                            6.6.4.2. Regulatory framework/ reimbursement structure
                            6.6.4.3. Competitive scenario
                            6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
                        6.6.5. Spain
                            6.6.5.1. Key country dynamics
                            6.6.5.2. Regulatory framework/ reimbursement structure
                            6.6.5.3. Competitive scenario
                            6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
                        6.6.6. Norway
                            6.6.6.1. Key country dynamics
                            6.6.6.2. Regulatory framework/ reimbursement structure
                            6.6.6.3. Competitive scenario
                            6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
                        6.6.7. Sweden
                            6.6.7.1. Key country dynamics
                            6.6.7.2. Regulatory framework/ reimbursement structure
                            6.6.7.3. Competitive scenario
                            6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
                        6.6.8. Denmark
                            6.6.8.1. Key country dynamics
                            6.6.8.2. Regulatory framework/ reimbursement structure
                            6.6.8.3. Competitive scenario
                            6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
                    6.7. Asia Pacific
                        6.7.1. Japan
                            6.7.1.1. Key country dynamics
                            6.7.1.2. Regulatory framework/ reimbursement structure
                            6.7.1.3. Competitive scenario
                            6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
                        6.7.2. China
                            6.7.2.1. Key country dynamics
                            6.7.2.2. Regulatory framework/ reimbursement structure
                            6.7.2.3. Competitive scenario
                            6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
                        6.7.3. India
                            6.7.3.1. Key country dynamics
                            6.7.3.2. Regulatory framework/ reimbursement structure
                            6.7.3.3. Competitive scenario
                            6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
                        6.7.4. Australia
                            6.7.4.1. Key country dynamics
                            6.7.4.2. Regulatory framework/ reimbursement structure
                            6.7.4.3. Competitive scenario
                            6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
                        6.7.5. South Korea
                            6.7.5.1. Key country dynamics
                            6.7.5.2. Regulatory framework/ reimbursement structure
                            6.7.5.3. Competitive scenario
                            6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
                        6.7.6. Thailand
                            6.7.6.1. Key country dynamics
                            6.7.6.2. Regulatory framework/ reimbursement structure
                            6.7.6.3. Competitive scenario
                            6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
                    6.8. Latin America
                        6.8.1. Brazil
                            6.8.1.1. Key country dynamics
                            6.8.1.2. Regulatory framework/ reimbursement structure
                            6.8.1.3. Competitive scenario
                            6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
                        6.8.2. Argentina
                            6.8.2.1. Key country dynamics
                            6.8.2.2. Regulatory framework/ reimbursement structure
                            6.8.2.3. Competitive scenario
                            6.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
                    6.9. MEA
                        6.9.1. South Africa
                            6.9.1.1. Key country dynamics
                            6.9.1.2. Regulatory framework/ reimbursement structure
                            6.9.1.3. Competitive scenario
                            6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
                        6.9.2. Saudi Arabia
                            6.9.2.1. Key country dynamics
                            6.9.2.2. Regulatory framework/ reimbursement structure
                            6.9.2.3. Competitive scenario
                            6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
                        6.9.3. UAE
                            6.9.3.1. Key country dynamics
                            6.9.3.2. Regulatory framework/ reimbursement structure
                            6.9.3.3. Competitive scenario
                            6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
                        6.9.4. Kuwait
                            6.9.4.1. Key country dynamics
                            6.9.4.2. Regulatory framework/ reimbursement structure
                            6.9.4.3. Competitive scenario
                            6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million) (Number of Patients Treated in Thousands)
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis, By Key Market Participants
                    7.2. Company/Competition Categorization
                    7.3. Vendor Landscape
                        7.3.1. List of key distributors and channel partners
                        7.3.2. Key customers
                        7.3.3. Key company market share analysis, 2023
                        7.3.4. Omron Healthcare Welch Allyn, Inc.
                            7.3.4.1. Company overview
                            7.3.4.2. Financial performance
                            7.3.4.3. Product benchmarking
                            7.3.4.4. Strategic initiatives
                        7.3.5. A&D Medical Inc.
                            7.3.5.1. Company overview
                            7.3.5.2. Financial performance
                            7.3.5.3. Product benchmarking
                            7.3.5.4. Strategic initiatives
                        7.3.6. Microlife Corporation
                            7.3.6.1. Company overview
                            7.3.6.2. Financial performance
                            7.3.6.3. Product benchmarking
                            7.3.6.4. Strategic initiatives
                        7.3.7. Daray Medical
                            7.3.7.1. Company overview
                            7.3.7.2. Financial performance
                            7.3.7.3. Product benchmarking
                            7.3.7.4. Strategic initiatives
                        7.3.8. Withings
                            7.3.8.1. Company overview
                            7.3.8.2. Financial performance
                            7.3.8.3. Product benchmarking
                            7.3.8.4. Strategic initiatives
                        7.3.9. Briggs Healthcare
                            7.3.9.1. Company overview
                            7.3.9.2. Financial performance
                            7.3.9.3. Product benchmarking
                            7.3.9.4. Strategic initiatives
                        7.3.10. GE Healthcare
                            7.3.10.1. Company overview
                            7.3.10.2. Financial performance
                            7.3.10.3. Product benchmarking
                            7.3.10.4. Strategic initiatives
                        7.3.11. Rossmax International Ltd.
                            7.3.11.1. Company overview
                            7.3.11.2. Financial performance
                            7.3.11.3. Product benchmarking
                            7.3.11.4. Strategic initiatives
                        7.3.12. GF Health Products Inc
                            7.3.12.1. Company overview
                            7.3.12.2. Financial performance
                            7.3.12.3. Product benchmarking
                            7.3.12.4. Strategic initiatives
                        7.3.13. Spacelabs Healthcare Inc.
                            7.3.13.1. Company overview
                            7.3.13.2. Financial performance
                            7.3.13.3. Product benchmarking
                            7.3.13.4. Strategic initiatives
                        7.3.14. Philips Healthcare
                            7.3.14.1. Company overview
                            7.3.14.2. Financial performance
                            7.3.14.3. Product benchmarking
                            7.3.14.4. Strategic initiatives
                        7.3.15. Biobeat
                            7.3.15.1. Company overview
                            7.3.15.2. Financial performance
                            7.3.15.3. Product benchmarking
                            7.3.15.4. Strategic initiatives
                        7.3.16. Spacelabs Healthcare Inc
                            7.3.16.1. Company overview
                            7.3.16.2. Financial performance
                            7.3.16.3. Product benchmarking
                            7.3.16.4. Strategic initiatives
                        7.3.17. Bosch & Sohn GmbH & Co. KG
                            7.3.17.1. Company overview
                            7.3.17.2. Financial performance
                            7.3.17.3. Product benchmarking
                            7.3.17.4. Strategic initiatives
                        7.3.18. GE Company,
                            7.3.18.1. Company overview
                            7.3.18.2. Financial performance
                            7.3.18.3. Product benchmarking
                            7.3.18.4. Strategic initiatives
                        7.3.19. Schiller AG
                            7.3.19.1. Company overview
                            7.3.19.2. Financial performance
                            7.3.19.3. Product benchmarking
                            7.3.19.4. Strategic initiatives
                        7.3.20. DAIFUKU CO. LTD
                            7.3.20.1. Company overview
                            7.3.20.2. Financial performance
                            7.3.20.3. Product benchmarking
                            7.3.20.4. Strategic initiative

List of Tables

Table 1. List of abbreviation
Table 2. North America ambulatory blood pressure monitoring devices market, by country (USD Million) (Number of Patients Treated in Thousands) 2018-2030
Table 3. North America ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 4. North America ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 5. U.S. ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 6. U.S. ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 7. Canada ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 8. Canada ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 9. Mexico ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 10. Mexico ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 11. Europe ambulatory blood pressure monitoring devices market, by country (USD Million) (Number of Patients Treated in Thousands) 2018-2030
Table 12. Europe ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 13. Europe ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 14. Germany ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 15. Germany ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 16. UK ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 17. UK ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 18. France ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 19. France ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 20. Italy ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 21. Italy ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 22. Spain ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 23. Spain ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 24. Denmark ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 25. Denmark ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 26. Sweden ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 27. Sweden ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 28. Norway ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 29. Norway ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 30. Asia Pacific ambulatory blood pressure monitoring devices market, by country (USD Million) (Number of Patients Treated in Thousands) 2018-2030
Table 31. Asia Pacific ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 32. Asia Pacific ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 33. China ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 34. China ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 35. Japan ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 36. Japan ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 37. India ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 38. India ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 39. South Korea ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 40. South Korea ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 41. Australia ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 42. Australia ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 43. Thailand ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 44. Thailand ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 45. Latin America ambulatory blood pressure monitoring devices market, by country (USD Million) (Number of Patients Treated in Thousands) 2018-2030
Table 46. Latin America ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 47. Latin America ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 48. Brazil ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 49. Brazil ambulatory blood pressure monitoring devices market, by end-use (USD Million) 2018-20
Table 50. Argentina ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 51. Argentina ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 52. MEA ambulatory blood pressure monitoring devices market, by country (USD Million) (Number of Patients Treated in Thousands) 2018-2030
Table 53. MEA ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 54. MEA ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 55. South Africa ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 56. South Africa ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 57. Saudi Arabia ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 58. Saudi Arabia ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 59. UAE ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 60. UAE ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 61. Kuwait ambulatory blood pressure monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 62. Kuwait ambulatory blood pressure monitoring devices market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Ambulatory blood pressure monitoring devices market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Competitive landscape snapshot
Fig. 10 Market dynamics
Fig. 11 Prevalence of rheumatoid arthritis in 2022, by WHO regions
Fig. 12 Porter’s five forces analysis
Fig. 13 PESTLE analysis
Fig. 14 Ambulatory blood pressure monitoring devices market: Products outlook and key takeaways
Fig. 15 Ambulatory blood pressure monitoring devices market: Product movement analysis
Fig. 16 Ambulatory blood pressure monitors market estimates and forecast, 2018-2030 (USD Million)
Fig. 17 Instrument & accessories market estimates and forecast, 2018-2030 (USD Million)
Fig. 18 Blood pressure cuffs market estimates and forecast, 2018-2030 (USD Million)
Fig. 19 Others market estimates and forecast, 2018-2030, USD Million
Fig. 20 Ambulatory blood pressure monitoring devices market: End-use outlook and key takeaways
Fig. 21 Ambulatory blood pressure monitoring devices market: End-use movement analysis
Fig. 22 Hospitals market estimates and forecast, 2018-2030 (USD Million)
Fig. 23 Ambulatory Surgical Centers & Clinics market estimates and forecast, 2018-2030 (USD Million)
Fig. 24 Home-care market estimates and forecast, 2018-2030 (USD Million)
Fig. 25 Provincial marketplace: Key takeaways (1/2)
Fig. 26 Provincial marketplace: Key takeaways (2/2)
Fig. 27 North America ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 28 Key country dynamics
Fig. 29 U.S. ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 30 Key country dynamics
Fig. 31 Canada ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 32 Europe ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 33 Key country dynamics
Fig. 34 UK ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 35 Key country dynamics
Fig. 36 Germany ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 37 Key country dynamics
Fig. 38 France ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 39 Key country dynamics
Fig. 40 Spain ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 41 Key country dynamics
Fig. 42 Italy ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 43 Key country dynamics
Fig. 44 Denmark ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 45 Key country dynamics
Fig. 46 Sweden ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 47 Key country dynamics
Fig. 48 Norway ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 49 Rest of Europe Ambulatory blood pressure monitoring devices market estimates and forecasts, 2018-2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 50 Asia Pacific ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 51 Key country dynamics
Fig. 52 Reimbursement scenario
Fig. 53 Japan ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 54 Key country dynamics
Fig. 55 Regulatory framework
Fig. 56 Reimbursement scenario
Fig. 57 China ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 58 Key country dynamics
Fig. 59 Reimbursement scenario
Fig. 60 India ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 61 Key country dynamics
Fig. 62 Australia ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 63 Key country dynamics
Fig. 64 South Korea Ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 -2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 65 Key country dynamics
Fig. 66 Thailand ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 67 Key country dynamics
Fig. 68 Malaysia ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 69 Key country dynamics
Fig. 70 Vietnam ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 71 Key country dynamics
Fig. 72 Philippines ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 73 Rest of Asia Pacific Ambulatory blood pressure monitoring devices market estimates and forecasts, 2018-2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 74 Latin America ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 75 Key country dynamics
Fig. 76 Brazil regulation details
Fig. 77 Reimbursement scenario
Fig. 78 Brazil ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 79 Key country dynamics
Fig. 80 Argentina pharmaceuticals registration details
Fig. 81 Argentina ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 82 Key country dynamics
Fig. 83 Regulatory framework
Fig. 84 Reimbursement scenario
Fig. 85 Mexico ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 86 Rest of Latin America Ambulatory blood pressure monitoring devices market estimates and forecasts, 2018-2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 87 MEA Ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 88 Key country dynamics
Fig. 89 South Africa ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 90 Key country dynamics
Fig. 91 Saudi Arabia ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 92 Key country dynamics
Fig. 93 UAE Ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 94 Key country dynamics
Fig. 95 Kuwait ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 96 Key country dynamics
Fig. 97 Turkey ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 98 Rest of MEA ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 - 2030 (USD million) (Number of Patients Treated in Thousands)
Fig. 99 Company market share analysis, 2023
Fig. 100 Strategic framework